Spastisk dysfoni interviews
Den socioøkonomiske indvirkning af patienter med spastisk dysfoni og botulinumtoksinets rolle
Previous research has shown that patients with voice disorders often have a lower quality of life and struggle with employment. Spasmodic Dysphonia (SD) is a voice disorder that causes abrupt and uncontrollable spasms of the voice box, often resulting in the person having lifelong changes in their voice and speech pattern. The current mainstay of treatment is injecting botulinum toxin (BT) injections into the vocal cord to ease the spasms. The same research team conducted a pilot study in April 2021 on patients with SD. The pilot study used questionnaires and short interviews to understand the livelihood of 10 SD patients. It displayed that SD may impact patients' quality of life. The investigators now aim to run an official research project, ethically approved, to explore the following questions further:
- Does SD impact the socio-economic lives of its patients? If so, how?
- What role does BT play in the socio-economic livelihood of SD patients?
To answer these questions, the investigators aim to interview 20 patients with Spasmodic Dysphonia.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Manchester, Det Forenede Kongerige
- Manchester University NHS Foundation Trust
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Adult patients with diagnosed Spasmodic Dysphonia
Beskrivelse
Inclusion Criteria:
- Adults diagnosed with Spasmodic Dysphonia who have received at least one botulinum toxin injection.
Exclusion Criteria:
- Below 18 years of age; additional laryngeal condition(s) severely affecting voice.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: OTHER
- Tidsperspektiver: PROSPECTIVE
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Spasmodic Dysphonia patients
Adults diagnosed with Spasmodic Dysphonia who have received at least one botulinum toxin injection. |
Botulinum toxin injection to ease spasms of vocal cord |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Does Spasmodic Dysphonia impact the socio-economic lives of its patients? If so, how?
Tidsramme: Through study completion, which is expected to be a year
|
Outcome will be measured through qualitative analysis of participant answers regarding how the target condition, spasmodic dysphonia, affects the social and economic aspects of their livelihood. |
Through study completion, which is expected to be a year
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
What role do botulinum toxin injections play in the socio-economic livelihood of Spasmodic Dysphonia patients?
Tidsramme: Through study completion, which is expected to be a year
|
Outcome will be measured through qualitative analysis of participant answers regarding how receiving Botulinum toxin injections may improve their livelihood. |
Through study completion, which is expected to be a year
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Sadie Khwaja, MBChB, Manchester University NHS Foundation Trust
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- B01796
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Individual participant data will not be shared due to the sensitive nature of the study content and the interview study design
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .